Core Viewpoint - The article emphasizes the importance of investing in defensive stocks amid recent market volatility, highlighting five specific stocks that are well-positioned for stability and growth in uncertain economic conditions [2][4][5]. Group 1: Market Conditions - U.S. stock markets experienced significant volatility in March due to concerns over the sustainability of the AI trade, ongoing geopolitical tensions, rising crude oil and gas prices, inflation expectations, and uncertainty regarding the Federal Reserve's interest rate policy [2]. - The Nasdaq Composite and Dow are in correction territory, trading below 10% from recent highs, while the S&P 500 has recorded its fifth consecutive weekly decline, trading below 8.7% from its recent peak [3]. Group 2: Stock Selection Criteria - Investment in defensive stocks is recommended to safeguard portfolio returns in the near term, focusing on sectors such as utilities, consumer staples, and healthcare [4]. - Stocks selected should be low-beta (beta >0<1) and regularly pay dividends [4]. Group 3: Featured Stocks - **Duke Energy Corp. (DUK)**: Plans to invest $103 billion from 2026-2030 to enhance its grid and expand renewable energy initiatives. DUK has a revenue growth rate of 3.3% and earnings growth rate of 6.3% for the current year, with a dividend yield of 3.28% and a beta of 0.50 [6][10][11]. - **Entergy Corp. (ETR)**: Aims to invest $41 billion from 2026-2029 for infrastructure upgrades and renewable expansion. ETR has a revenue growth rate of 6.8% and earnings growth rate of 12.8% for the current year, with a dividend yield of 2.33% and a beta of 0.64 [12][13]. - **Constellation Brands Inc. (STZ)**: Successfully transitioning to premium brands, with a revenue growth rate of 1.5% and earnings growth rate of 6.5% for the current year, alongside a dividend yield of 2.69% and a beta of 0.44 [14][16]. - **The Coca-Cola Co. (KO)**: Benefits from strong organic revenue growth and effective pricing strategies, with a revenue growth rate of 3.2% and earnings growth rate of 8% for the current year, a dividend yield of 2.80% and a beta of 0.35 [17][19]. - **Johnson & Johnson (JNJ)**: The Innovative Medicine unit shows growth despite exclusivity loss, with a revenue growth rate of 6.6% and earnings growth rate of 7% for the current year, a dividend yield of 2.16% and a beta of 0.34 [20][22].

Market Overview - U.S. stock markets experienced significant volatility in March due to concerns over the sustainability of the AI trade, ongoing geopolitical tensions, rising crude oil and gas prices, inflationary expectations, and uncertainty regarding the Federal Reserve's interest rate policy [2] - The Nasdaq Composite and Dow are in correction territory, trading below 10% from recent highs, while the S&P 500 has recorded its largest losing streak since 2022, down 8.7% from its recent peak [3] Stock Selection Criteria - Investment in defensive stocks is recommended to safeguard portfolio returns in the near term, focusing on sectors such as utilities, consumer staples, and healthcare [4] - Selection of low-beta stocks that regularly pay dividends is advised [4] Selected Stocks - Five stocks with favorable Zacks Rank identified: Duke Energy Corp. (DUK), Entergy Corp. (ETR), Constellation Brands Inc. (STZ), The Coca-Cola Co. (KO), and Johnson & Johnson (JNJ), all carrying a Zacks Rank 2 (Buy) [5] Duke Energy Corp. (DUK) - DUK plans to invest $103 billion from 2026 to 2030 to enhance grid strength and expand its renewable energy portfolio [8][9] - The company is actively pursuing nuclear energy expansion and has made progress in reducing carbon emissions [10] - DUK has an expected revenue growth rate of 3.3% and earnings growth rate of 6.3% for the current year, with a current dividend yield of 3.28% and a beta of 0.50 [13] Entergy Corp. (ETR) - ETR plans to invest $41 billion from 2026 to 2029 for infrastructure upgrades and renewable expansion [14] - The company aims to add 275 MW of nuclear power through upgrades and has secured a permit for a new nuclear reactor [15] - ETR has an expected revenue growth rate of 6.8% and earnings growth rate of 12.8% for the current year, with a current dividend yield of 2.33% and a beta of 0.64 [15] Constellation Brands Inc. (STZ) - STZ's premiumization strategy is driving growth, particularly in its Wine and Spirits business, with key brands showing strong performance [16] - The beer segment continues to outperform the broader industry, with solid growth from brands like Pacifico and Victoria [17] - STZ has an expected revenue growth rate of 1.5% and earnings growth rate of 6.5% for the current year, with a current dividend yield of 2.69% and a beta of 0.44 [18] The Coca-Cola Co. (KO) - KO benefits from a strong strategy and resilient global portfolio, with solid organic revenue growth and effective pricing actions [20] - The company's focus on innovation and digital transformation enhances its competitive edge [21] - KO has an expected revenue growth rate of 3.2% and earnings growth rate of 8% for the current year, with a current dividend yield of 2.80% and a beta of 0.35 [22] Johnson & Johnson (JNJ) - JNJ's Innovative Medicine unit is showing growth despite the loss of exclusivity of key products, driven by new launches and existing strong products [23] - The MedTech segment has shown operational growth across key businesses [23] - JNJ has an expected revenue growth rate of 6.6% and earnings growth rate of 7% for the current year, with a current dividend yield of 2.16% and a beta of 0.34 [24]

Core Viewpoint - Diageo is undergoing a painful restructuring with declining sales and a reduced dividend, while Constellation Brands is experiencing growth and maintaining a stable dividend, making it the preferable choice for income-focused investors [2][4][11]. Dividend and Income - Diageo has rebased its interim dividend to $0.20 per share, with a new minimum annual floor of $0.50, indicating a shift towards debt reduction over income [6]. - Constellation Brands maintains a quarterly dividend of $1.02 ($4.08 annualized), which has been consistently reaffirmed, providing stability for income-dependent investors [7]. Growth Trajectory - Diageo anticipates a 2% to 3% organic sales decline in FY2026, with significant drops in U.S. spirits sales (down 9.3%) and a 50.4% collapse in China white spirits volumes [3][7]. - In contrast, Constellation Brands has achieved its 15th consecutive year of beer volume growth, with notable increases in brands like Pacifico (over 15% growth) and Victoria (over 13% growth) [8]. Valuation and Risk - Diageo's stock has decreased by 29.7% over the past year and is down 14.5% year-to-date, trading below its 200-day moving average of $96.41, with a challenging path to the analyst consensus target of $105.29 due to high leverage and ongoing restructuring [9]. - Constellation Brands has seen a 17.9% decline over the past year but has recovered 9.7% year-to-date, with a current price near $151.40 and an analyst consensus target of $171.86 [10]. Conclusion - Diageo is not deemed uninvestable due to potential growth in its Guinness brand and expected proceeds from asset sales, but it is more suitable for risk-tolerant investors with a long-term horizon [10]. - For retirement-focused investors seeking income stability and a clearer growth path, Constellation Brands is the better option, given its consistent dividend, strong beer business, and positive stock momentum [11].

Group 1 - Constellation Brands, Inc. (NYSE:STZ) is considered one of the best undervalued defensive stocks for 2026, with a recent upgrade from Citi to Buy and a price target increase from $155 to $175 [1] - Citi's research indicates that beer scanner data has shown improvement ahead of the summer season, and the company's comparisons remain favorable through 2026, cycling through last year's beer category weakness [1] - The upgrade is also attributed to the stock's historically low valuation levels and improved sales trends [1] Group 2 - Constellation Brands announced a CEO succession plan, appointing Nicholas Fink as the next President and CEO effective April 13, 2026, succeeding Bill Newlands [2] - Nicholas Fink has been a member of the company's Board of Directors since 2021 and will continue to serve on the Board after his appointment [2] Group 3 - Constellation Brands, Inc. produces, markets, and distributes wine, beer, and spirits, operating through various segments including Beer, Wine, Spirits, Corporate Operations and Other, and Canopy [3]

Company Overview - Constellation Brands, Inc. is a leading beverage alcohol company based in New York, known for its premium portfolio of imported beer, wine, and spirits, with a market cap of $25 billion [1] Earnings Expectations - The company is expected to announce its fourth-quarter earnings for 2026 on April 8, 2026, with analysts predicting a profit of $1.73 per share, a decrease of 34.2% from $2.63 per share in the same quarter last year [2] - For the fiscal year ending February 2026, analysts anticipate an EPS of $11.64, down 15.5% from $13.78 in fiscal 2025, but expect a rise of 6.5% year over year to $12.40 in fiscal 2027 [3] Earnings History - In the previous quarters, Constellation Brands reported earnings as follows: Qtr Ending 02/25: $2.63, Qtr Ending 05/25: $3.22, Qtr Ending 08/25: $3.63, Qtr Ending 11/25: $3.06, with a mix of surprises against estimates [4] Stock Performance - STZ stock has declined by 15.3% over the past year, underperforming the S&P 500 Index, which gained 13.7%, and the State Street Consumer Staples Select Sector SPDR Fund, which rose by 2.2% [4] Market Challenges - The decline in stock performance is attributed to slowing growth and margin pressures in the core beer segment, rising input costs, increased marketing and capacity investments, and softer-than-expected demand growth [5] Analyst Ratings - Analysts maintain a moderately bullish outlook on STZ stock, with a consensus rating of "Moderate Buy." Out of 24 analysts, 10 recommend "Strong Buy," 3 suggest "Moderate Buy," 9 give "Hold," 1 advises "Moderate Sell," and 1 recommends "Strong Sell." The average price target is $171.68, indicating a potential upside of 12.4% from current levels [6]

Core Viewpoint - Constellation Brands Inc (NYSE:STZ) has received an upgrade from Citigroup, which has raised its price target, indicating potential for a rally in the stock due to expected growth in beer sales, particularly during the FIFA World Cup [1] Group 1: Stock Performance - STZ stock is currently trading at $151.92, reflecting a 0.3% increase following the upgrade [1] - The stock has experienced a decline of 15.3% over the past 12 months, despite holding a +10% year-to-date level [2] Group 2: Analyst Sentiment - The brokerage community is divided on STZ, with 12 out of 24 firms maintaining a "hold" or worse rating [2] - The recent upgrade to "buy" from Citigroup suggests a shift in sentiment, anticipating faster beer sales growth [1] Group 3: Market Dynamics - Short interest in STZ represents 5.6% of the equity's available float, although it has decreased by 14% in the last month [2] - Options for Constellation Brands are currently considered affordable, with a Schaeffer's Volatility Index (SVI) of 36%, indicating low volatility expectations among near-term option traders [3]

Core Insights - Diageo, Constellation Brands, and Ambev present distinct investment opportunities in the global drinks trade, with varying financial performances and strategic focuses [4][16]. Diageo - Diageo reported H1 FY2026 net sales of $10.46 billion, a decrease of 4.0% year-over-year, primarily due to a 7.4% decline in North America and a 13.0% drop in Asia Pacific [7][4]. - The company cut its dividend to address a leverage ratio of 3.4x, which exceeds its target range of 2.5-3.0x [7][4]. - Tequila brands, particularly Don Julio and Casamigos, experienced significant declines, with organic sales dropping 20.9% and 30.9% respectively [7][4]. - New CEO Sir Dave Lewis sees opportunities for enhancing competitiveness and broadening the portfolio, although the stock has fallen 26.48% over the past year [8][4]. Constellation Brands - Constellation's revenue for the quarter was $2.22 billion, down 9.8% year-over-year, but the organic decline was only about 2% after accounting for divestitures [9][4]. - The beer segment maintained a strong operating margin of 38.0%, despite facing aluminum tariff pressures [9][4]. - Growth drivers include Pacifico and Victoria, with depletions increasing over 15% and 13% respectively, while Modelo Especial remains the top-selling beer brand in the U.S. [9][4]. - The company is focusing on expanding its Mexican beer imports while managing tariff challenges [2][4]. Ambev - Ambev achieved a full-year 2025 EBITDA margin of 33.4%, marking a 50 basis point improvement and the third consecutive year of margin expansion [10][4]. - The company reported high-single-digit growth in premium and super-premium beer volumes, alongside a 70% growth in GMV for its BEES B2B platform [10][4]. - Ambev's digital distribution infrastructure is seen as a competitive advantage in the Latin American market [2][4]. - The company is trading at a forward P/E of around 14x with a dividend yield near 11%, indicating strong recent profit growth [16][4]. Comparative Analysis - Diageo's core bet is on the recovery of premium spirits, while Constellation focuses on Mexican beer imports, and Ambev emphasizes Latin American beer and digital distribution [11][4]. - Key risks for Diageo include balance sheet issues and U.S. consumer trends, for Constellation, tariff impacts on imports, and for Ambev, foreign exchange risks and inflation in Argentina [11][4]. - Bright spots for Diageo include growth in Guinness and ready-to-drink (RTD) products, while Constellation benefits from Pacifico and Victoria, and Ambev sees premium beer volume growth and BEES platform success [11][4].

Core Thesis - Constellation Brands, Inc. (STZ) is viewed positively due to its strong market position, brand strength, and operational control, which contribute to consistent growth in the beer and beverage industry [3][4][5] Company Performance - STZ's share price was $148.32 as of March 12th, with trailing and forward P/E ratios of 23.54 and 11.96 respectively [1] - Modelo Especial has surpassed Bud Light to become the top-selling beer in the U.S. by sales dollars, indicating a shift towards premium Mexican imports [3] Competitive Advantages - The company has a robust distribution network and a strong balance sheet, providing pricing power and brand loyalty, which are essential for maintaining a competitive edge [4] - STZ's disciplined brand positioning and focus on premiumization allow for ongoing margin expansion, even in a mature market [4] Investment Appeal - Investors may find STZ attractive due to its stable cash flow, strong market position, and potential for growth driven by consumer preference for premium beverages [5] - The operational strength and cultural relevance of STZ position it for sustainable long-term growth, making it a compelling investment in the consumer staples sector [5] Market Sentiment - At the end of the fourth quarter, 53 hedge fund portfolios held STZ, an increase from 50 in the previous quarter, indicating growing interest [7] - Despite the positive outlook, there is a belief that certain AI stocks may offer higher returns in a shorter timeframe compared to STZ [7]

Core Insights - Constellation Brands, Inc. (STZ) is a leading player in the beer, wine, and spirits market, focusing on premiumization, brand strength, and disciplined portfolio management [1][5] - The company has a strong portfolio of consumer-driven brands, including Modelo Especial, Corona Extra, and Robert Mondavi Winery, positioning it well to capture growth opportunities [1][4] Strategy and Growth Drivers - The company's strategy centers on high-growth premium brands to strengthen market share, improve margins, and drive sustainable growth [2][5] - Key growth drivers include high-end Power Brands like The Prisoner Brand Family and Kim Crawford, with the beer segment benefiting from premiumization trends [3][9] - Constellation Brands is investing in capacity expansion in Mexico to support its brand growth [3][9] Market Position and Performance - The company emphasizes high-margin growth categories in the beverage alcohol industry, leveraging direct-to-consumer platforms and a strong global presence [4] - STZ's beer brands, including Modelo, Corona, and Pacifico, reinforce its leadership in the U.S. beer market [4][9] Financial Performance and Estimates - Constellation Brands' shares have gained 7.6% over the past six months, compared to the industry's growth of 9.7% [6] - The company trades at a forward price-to-earnings ratio of 12.09X, below the industry average of 15.17X [7] - The Zacks Consensus Estimate for STZ's fiscal 2026 earnings indicates a year-over-year decline of 15.5%, while fiscal 2027 shows an expected growth of 6.5% [10]

Core Insights - Constellation Brands (STZ) has experienced significant changes over the past year, including the impact of tariffs on its beer business, the divestiture of six wine brands, and the appointment of a new CEO [1] Group 1: Business Changes - The beer business has been affected by tariffs, which may influence pricing and market competitiveness [1] - The company has divested six wine brands, indicating a strategic shift in its portfolio management [1] - A new CEO has been appointed, which could lead to changes in corporate strategy and operational focus [1]